OBJECTIVE
To determine the associated clinical symptoms and prevalence of Blastocystis hominis (B. hominis).
METHODS
Stool samples of 50,185 patients (26,784 males and 23,401 females) who were received at the Parasitology Laboratory of Yuzuncu Yil University Faculty of Medicine, Van, Turkey in the